215 related articles for article (PubMed ID: 22649557)
1. NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected].
Subramanian L; Blumenfeld H; Tohn R; Ly D; Aguilera C; Maricic I; Mansson JE; Buschard K; Kumar V; Delovitch TL
PLoS One; 2012; 7(5):e37771. PubMed ID: 22649557
[TBL] [Abstract][Full Text] [Related]
2. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.
Blomqvist M; Rhost S; Teneberg S; Löfbom L; Osterbye T; Brigl M; Månsson JE; Cardell SL
Eur J Immunol; 2009 Jul; 39(7):1726-35. PubMed ID: 19582739
[TBL] [Abstract][Full Text] [Related]
3. CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes.
Kadri N; Korpos E; Gupta S; Briet C; Löfbom L; Yagita H; Lehuen A; Boitard C; Holmberg D; Sorokin L; Cardell SL
J Immunol; 2012 Apr; 188(7):3138-49. PubMed ID: 22371394
[TBL] [Abstract][Full Text] [Related]
4. Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells.
Kent SC; Chen Y; Clemmings SM; Viglietta V; Kenyon NS; Ricordi C; Hering B; Hafler DA
J Immunol; 2005 Oct; 175(7):4458-64. PubMed ID: 16177088
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells.
Mi QS; Ly D; Zucker P; McGarry M; Delovitch TL
Diabetes; 2004 May; 53(5):1303-10. PubMed ID: 15111500
[TBL] [Abstract][Full Text] [Related]
6. Administration of sulfatide to ameliorate type I diabetes in non-obese diabetic mice.
Rhost S; Lofbom L; Mansson J-; Lehuen A; Blomqvist M; Cardell SL
Scand J Immunol; 2014 Apr; 79(4):260-6. PubMed ID: 24795987
[TBL] [Abstract][Full Text] [Related]
7. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.
Falcone M; Facciotti F; Ghidoli N; Monti P; Olivieri S; Zaccagnino L; Bonifacio E; Casorati G; Sanvito F; Sarvetnick N
J Immunol; 2004 May; 172(10):5908-16. PubMed ID: 15128771
[TBL] [Abstract][Full Text] [Related]
10. Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice.
Blumenfeld HJ; Tohn R; Haeryfar SM; Liu Y; Savage PB; Delovitch TL
Clin Exp Immunol; 2011 Oct; 166(1):121-33. PubMed ID: 21910729
[TBL] [Abstract][Full Text] [Related]
11. Sulfatide inhibits α-galactosylceramide presentation by dendritic cells.
Kanamori M; Tasumi Y; Iyoda T; Ushida M; Inaba K
Int Immunol; 2012 Feb; 24(2):129-36. PubMed ID: 22247226
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells and anergic type I NKT cells play a crucial role in sulfatide-mediated immune regulation in experimental autoimmune encephalomyelitis.
Maricic I; Halder R; Bischof F; Kumar V
J Immunol; 2014 Aug; 193(3):1035-46. PubMed ID: 24973441
[TBL] [Abstract][Full Text] [Related]
13. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets.
Naumov YN; Bahjat KS; Gausling R; Abraham R; Exley MA; Koezuka Y; Balk SB; Strominger JL; Clare-Salzer M; Wilson SB
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13838-43. PubMed ID: 11707602
[TBL] [Abstract][Full Text] [Related]
14. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
Ly D; Mi QS; Hussain S; Delovitch TL
J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes.
Beaudoin L; Diana J; Ghazarian L; Simoni Y; Boitard C; Lehuen A
Eur J Immunol; 2014 May; 44(5):1454-66. PubMed ID: 24481989
[TBL] [Abstract][Full Text] [Related]
16. Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice.
Mattner J; Mohammed JP; Fusakio ME; Giessler C; Hackstein CP; Opoka R; Wrage M; Schey R; Clark J; Fraser HI; Rainbow DB; Wicker LS
PLoS Genet; 2019 Jun; 15(6):e1008178. PubMed ID: 31199784
[TBL] [Abstract][Full Text] [Related]
17. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes.
Chen YG; Choisy-Rossi CM; Holl TM; Chapman HD; Besra GS; Porcelli SA; Shaffer DJ; Roopenian D; Wilson SB; Serreze DV
J Immunol; 2005 Feb; 174(3):1196-204. PubMed ID: 15661873
[TBL] [Abstract][Full Text] [Related]
18. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal processing of sulfatide analogs alters target NKT cell specificity and immune responses in cancer.
Nishio K; Pasquet L; Camara K; DiSapio J; Hsu KS; Kato S; Bloom A; Richardson SK; Welsh JA; Jiang T; Jones JC; Cardell S; Watarai H; Terabe M; Olkhanud PB; Howell AR; Berzofsky JA
J Clin Invest; 2023 Dec; 134(4):. PubMed ID: 38127463
[TBL] [Abstract][Full Text] [Related]
20. Sulfatide-activated type II NKT cells suppress immunogenic maturation of lung dendritic cells in murine models of asthma.
Pan H; Zhang G; Nie H; Li S; He S; Yang J
Am J Physiol Lung Cell Mol Physiol; 2019 Nov; 317(5):L578-L590. PubMed ID: 31432714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]